Determining the Optimal SARS-CoV-2 mRNA Vaccine Dosing Interval for Maximum Immunogenicity

Objective: Emerging evidence indicates that longer SARS-CoV-2 vaccine dosing intervals results in an enhanced immune response. However, the optimal vaccine dosing interval for achieving maximum immunogenicity is unclear. Methods: This study included samples from adult paramedics in Canada who receiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Asamoah-Boaheng, Michael, Goldfarb, David, Prusinkiewicz, Martin A, Golding, Liam, Karim, Mohammad E, Barakauskas, Vilte, Wall, Nechelle, Jassem, Agatha N, Marquez, Ana Citlali, MacDonald, Chris, O’Brien, Sheila F, Lavoie, Pascal, Grunau, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Infectious Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981229/
https://www.ncbi.nlm.nih.gov/pubmed/36874687
http://dx.doi.org/10.7759/cureus.34465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981229/
https://www.ncbi.nlm.nih.gov/pubmed/36874687
http://dx.doi.org/10.7759/cureus.34465

Ejemplares similares